Chinese herbal capsule for fatty liver disease
Part of Digestive system clinical trials.
This trial tests a traditional Chinese herbal capsule (Linzhi Jianghuang Fufang) to treat non-alcoholic fatty liver disease—a buildup of fat in the liver not caused by alcohol. The study aims to see if this herbal treatment can safely reduce liver fat and improve metabolic health in people with early-stage fatty liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Confirmed fatty liver with at least 10% fat content on MRI scan, but without advanced scarring
- At least one metabolic risk factor: prediabetes/diabetes, high blood pressure, or high triglycerides
- Symptoms matching Traditional Chinese Medicine diagnosis (like rib pain, abdominal fullness, dark complexion, obesity, plus tongue/pulse findings)
- No heavy alcohol use, other liver diseases, or severe heart, kidney, or immune system problems
- Stable medications for at least 3 months; no recent weight-loss surgery or major surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests Ganzhixiao capsules for people with MAFLD (a type of fatty liver disease) who also have symptoms of 'damp heat' (like feeling heavy and sluggish). It aims to see if the capsules can help improve liver health.
This trial tests whether Fuzheng Huayu tablets can help people with fatty liver disease that has progressed to cirrhosis (scarring) that is still compensated (the liver is still working well). The goal is to see if the tablets slow or reverse liver damage.
This study tests a Chinese herbal formula called Longqi Jiangzhi Decoction for people with non-alcoholic fatty liver disease (NAFLD) who also have a Traditional Chinese Medicine pattern of 'Spleen Deficiency with Damp-Heat'. If you qualify, you will receive the herbal decoction to see if it can reduce liver fat and improve your health.
This trial studies whether LivPhcD capsules can improve fatty liver disease and checks for side effects. It may help people with non-alcohol-related fatty liver disease who meet specific liver-scanning and lab results.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
This trial tests a natural substance called Calculus Bovis Sativus to see if it can help people with metabolic fatty liver disease (MAFLD). It aims to improve liver health and reduce fat in the liver.
Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.